| Today's Open | $0.00 |
|---|---|
| Previous Close | $0.00 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $0.00 - $0.00 |
| Market Cap | $0.00 |
| P/E Ratio | 0.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 0 |
| Average Daily Volume | 0 |
| Current FY EPS | -$1.77 |
Sector
Healthcare
Industry
Drugs
MAP Pharmaceuticals (MAPP) Description
MAP Pharmaceuticals Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety efficacy and commercialization history. Website: http://www.mappharma.com/
News & Commentary
Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceutical
Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early
January Top 10: MAP Pharmaceuticals
A look back at January's most incredible health care stocks.AGN Earnings Miss but Guidance Tops - Analyst Blog
AGN Earnings Miss but Guidance Tops - Analyst BlogMAPP's Top Competitors
(0.00%)
(-0.45%)
(0.73%)
(0.61%)